Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,502 | 55,260 | 4,224 | 7,217 | 5,341 |
| Other current assets | 401 | 388 | 20 | 118 | 162 |
| TOTAL | $52,732 | $56,459 | $5,529 | $8,637 | $6,125 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 0 | 114 | 118 |
| Intangibles | 3,623 | 3,781 | 8,101 | 8,259 | 8,417 |
| TOTAL | $3,623 | $3,781 | $8,101 | $8,373 | $8,534 |
| Total Assets | $56,355 | $60,240 | $13,631 | $17,009 | $14,659 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,490 | 1,131 | 1,338 | 1,582 | 1,326 |
| Other current liabilities | N/A | 3,843 | 39 | 156 | 269 |
| TOTAL | $1,490 | $4,974 | $1,377 | $1,737 | $1,595 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 53 | 47 | 47 | 94 | 85 |
| TOTAL | $53 | $47 | $47 | $94 | $85 |
| Total Liabilities | $1,543 | $5,021 | $1,424 | $1,831 | $1,680 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,414 | 24,940 | 7,444 | 7,444 | 7,444 |
| Common Shares | 3 | 2 | 1 | 1 | 0 |
| Retained earnings | -72,880 | -70,011 | -59,900 | -56,862 | -53,146 |
| Other shareholders' equity | 47 | 19 | 18 | 6 | 0 |
| TOTAL | $54,813 | $55,219 | $12,207 | $15,178 | $12,979 |
| Total Liabilities And Equity | $56,355 | $60,240 | $13,631 | $17,009 | $14,659 |